Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Interventional Oncology Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
5.1.1.2. Increase in government expenditures for interventional oncology
5.1.1.3. Preference for minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Shortage of trained interventional oncologists
5.1.3. Opportunities
5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
5.1.3.2. New technological advancements for interventional oncology
5.1.4. Challenges
5.1.4.1. Presence of alternative therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Interventional Oncology Market, by Procedure
6.1. Introduction
6.2. Ablation
6.3. Particle Embolization
6.4. Radiation Therapy

7. Interventional Oncology Market, by Cancer Type
7.1. Introduction
7.2. Bone Metastasis
7.3. Breast Cancer
7.4. Kidney Cancer
7.5. Liver Cancer
7.6. Lung Cancer
7.7. Prostate Cancer

8. Interventional Oncology Market, by End-Users
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals
8.4. Research & Academic Institutes

9. Americas Interventional Oncology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Interventional Oncology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Interventional Oncology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Angiodynamics
13.1.2. Atricure
13.1.3. BALT Group
13.1.4. Boston Scientific Ltd.
13.1.5. Cook Medical
13.1.6. Eckert & Ziegler BEBIG AG
13.1.7. Integer Holding Corporation
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Medtronic PLC
13.1.10. Merit Medical
13.1.11. Profound Medical
13.1.12. Siemens Healthineers AG
13.1.13. Sonablate Corp
13.1.14. Stryker Corporation
13.1.15. Terumo Corporation
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 17. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 30. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 31. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 33. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 47. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 48. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 50. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 51. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 87. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 90. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 102. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 103. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 111. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 115. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 117. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 118. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 138. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 147. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. INTERVENTIONAL ONCOLOGY MARKET LICENSE & PRICING